DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol ▼ | Gene ID | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0015695 | Fatty Liver | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0600139 | Prostate carcinoma | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C1269683 | Major Depressive Disorder | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C1306459 | Primary malignant neoplasm | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0006826 | Malignant Neoplasms | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0752124 | Spinocerebellar Ataxia Type 6 (disorder) | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0752125 | Spinocerebellar Ataxia Type 7 | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C2711227 | Steatohepatitis | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0752120 | Spinocerebellar Ataxia Type 1 | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0028754 | Obesity | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C1864446 | Retinitis Pigmentosa 25 | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0752123 | Spinocerebellar Ataxia Type 5 | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0752121 | Spinocerebellar Ataxia Type 2 | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0752122 | Spinocerebellar Ataxia Type 4 | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0009398 | Color vision defect | ELOVL4 | 6785 | ELOVL fatty acid elongase 4 | Q9GZR5 |
C0020757 | Ichthyoses | ELOVL4 | 6785 | ELOVL fatty acid elongase 4 | Q9GZR5 |
C0242383 | Age related macular degeneration | ELOVL4 | 6785 | ELOVL fatty acid elongase 4 | Q9GZR5 |
C0036572 | Seizures | ELOVL4 | 6785 | ELOVL fatty acid elongase 4 | Q9GZR5 |
C0456909 | Blindness | ELOVL4 | 6785 | ELOVL fatty acid elongase 4 | Q9GZR5 |
C0020620 | Hypohidrosis | ELOVL4 | 6785 | ELOVL fatty acid elongase 4 | Q9GZR5 |
C0265961 | Erythrokeratodermia variabilis | ELOVL4 | 6785 | ELOVL fatty acid elongase 4 | Q9GZR5 |
C2239176 | Liver carcinoma | ELOVL4 | 6785 | ELOVL fatty acid elongase 4 | Q9GZR5 |
C1838644 | Stargardt disease 3 | ELOVL4 | 6785 | ELOVL fatty acid elongase 4 | Q9GZR5 |
C0015397 | Disorder of eye | ELOVL4 | 6785 | ELOVL fatty acid elongase 4 | Q9GZR5 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024